Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Phase 3

Posted by Matt Breese on Feb 23, 2017

Find me on:

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is restrictions. Healthcare and pharmaceutical regulations are intended to ensure drugs are safe and effective for patients.

Clinical trials are one method used to determine whether a treatment is effective. The U.S. Food and Drug Administration (FDA) is one of one of the world's leading authorities for evaluating clinical drug trials. 

Specifically, the "FDA ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations.  The CGMP regulations for drugs contain minimum requirements for the methods, facilities, and controls used in manufacturing, processing, and packing of a drug product.  The regulations make sure that a product is safe for use, and that it has the ingredients and strength it claims to have."  

View the graphic below, created by LillyPad, to learn more about the regulation process: 

Clinical Trials 1 .png

Clinical Trials 3.png


Subscribe to the MMIT blog for more insights on trends affecting pharmaceutical manufacturers, providers and payers.

Subscribe for Weekly Trends that Matter

Topics: Industry Trends